Press releases 2021

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2021-12-21 13:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO accelerates their business in Brazil by signing a partnership contract with Contatti Medical
2021-12-21 13:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO accelererar sin verksamhet i Brasilien genom att teckna ett partnerskapsavtal med Contatti Medical
2021-12-08 10:00
News
IR
English
Corporate Information
Staff change
In-line with XVIVO’s dedication to the US market, Fredrik Dalborg is appointed Managing Director North America
2021-12-08 10:00
News
IR
Swedish
Corporate Information
Staff change
I linje med XVIVOs fokus på den amerikanska marknaden har Fredrik Dalborg utsetts till Managing Director för Nordamerika
2021-11-30 08:00
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2021-11-30 08:00
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2021-11-22 15:00
News
IR
English
Corporate Information
Staff change
XVIVO expands its management team by appointing Jaya Tiwari to Vice President Clinical and Regulatory Affairs for the US
2021-11-22 15:00
News
IR
Swedish
Corporate Information
Staff change
XVIVO utökar sin ledningsgrupp genom att utse Jaya Tiwari till Vice President Clinical and Regulatory Affairs för USA
2021-11-09 19:45
News
IR
Swedish
Corporate Action
M&A
XVIVO slutför förvärvet av Star Teams Inc.
2021-11-09 19:45
News
IR
English
Corporate Action
M&A
XVIVO completes the acquisition of Star Teams Inc.
2021-10-28 21:58
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion has carried out a directed share issue of 746,269 shares at a subscription price of SEK 335 per share
2021-10-28 21:58
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion har genomfört en riktad nyemission av 746 269 aktier till en teckningskurs om 335 kronor per aktie
2021-10-28 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2021-10-28 17:31
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2021-10-28 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO has entered into an agreement to acquire the US organ recovery company Star Teams and finances the acquisition through a private placement of new shares
2021-10-28 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO har ingått avtal om att förvärva det amerikanska företaget för organhämtning, Star Teams, och finansierar förvärvet genom en nyemission av aktier
2021-10-21 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO offentliggör delårsrapport januari-september 2021
2021-10-21 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO presents interim report Januari-September 2021
2021-10-18 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Rekord för ett donatorhjärta utanför kroppen med banbrytande teknologi från XVIVO
2021-10-18 15:00
News
IR
English
Corporate Information
Other Corporate Information
Record for a donor heart outside the body using ground-breaking XVIVO technology
2021-10-07 15:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2021-10-07 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2021-10-05 11:30
News
IR
English
Corporate Information
Financial calendar
Advance publication of interim report January-September 2021
2021-10-05 11:30
News
IR
Swedish
Corporate Information
Financial calendar
Tidigareläggning av delårsrapport januari-september 2021
2021-09-30 08:30
News
IR
English
Corporate Information
Nomination Committee
Nomination committee of XVIVO Perfusion AB (publ)
2021-09-30 08:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2021-09-23 09:13
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Language correction: XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
2021-09-23 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO presenterar strategiska fokusområden för 2022-2026 på kapitalmarknadsdagen
2021-09-23 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
2021-08-23 17:00
News
IR
English
Corporate Information
Presentation
XVIVO Capital Markets Day 2021
2021-08-23 17:00
News
IR
Swedish
Corporate Information
Presentation
XVIVO’s kapitalmarknadsdag 2021
2021-07-13 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO offentliggör delårsrapport Januari-Juni 2021
2021-07-13 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO presents interim report January-June 2021
2021-07-08 15:45
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO startar sin digitala transformationsresa tillsammans med UMC Groningen för att möjliggöra en ökning av framgångsrika transplantationer
2021-07-08 15:45
News
IR
English
Corporate Information
Other Corporate Information
XVIVO to start their digital transformation journey together with UMC Groningen to enable an increase in successful transplants
2021-06-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2021-06-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2021-06-28 08:30
News
IR
English
Corporate Information
Financial calendar
Conference call on Interim Report
2021-06-28 08:30
News
IR
Swedish
Corporate Information
Financial calendar
Telefonkonferens avseende delårsrapport
2021-05-28 14:08
News
IR
Swedish
Corporate Information
Other Corporate Information
National Institute for Health and Care Excellence (NICE) i Storbritannien ger stöd för EVLP
2021-05-28 14:08
News
IR
English
Corporate Information
Other Corporate Information
The National Institute for Health and Care Excellence (NICE) Gives Support for EVLP
2021-05-25 10:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Stort intresse för XVIVO:s europeiska hjärtstudie
2021-05-25 10:30
News
IR
English
Corporate Information
Other Corporate Information
Great interest for XVIVO's European heart study
2021-05-04 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
510(k)-ansökan för Kidney Assist Transport inlämnad till amerikanska FDA
2021-05-04 07:30
News
IR
English
Corporate Information
Other Corporate Information
XVIVO submits 510(k) file with US FDA for Kidney Assist Transport
2021-04-22 16:12
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2021-04-22 16:12
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
2021-04-21 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Interim report January-March 2021
2021-04-21 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Delårsrapport januari-mars 2021
2021-04-19 08:30
News
IR
English
Corporate Information
Other Corporate Information
Australian heart preservation study underway
2021-04-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Första patienten transplanterad i australiensisk hjärtstudie.
2021-04-08 08:22
News
IR
Swedish
Correction
Corporate Information
Other Corporate Information
Rättelse: Telefonkonferens avseende delårsrapport
2021-04-08 07:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2021-04-08 07:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2021-03-29 12:35
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2020
2021-03-29 12:35
News
IR
English
Regulatory
VPML
Report
Annual
Annual report 2020
2021-03-15 08:50
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ)
2021-03-15 08:50
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2021-02-26 16:30
News
IR
English
Corporate Information
Other Corporate Information
Publication in The New England Journal of Medicine shows complications after liver transplantation significantly reduced with cold, oxygenated machine perfusion.
2021-02-26 16:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Publikation i The New England Journal of Medicine visar på signifikant minskning av komplikationer efter levertransplantation med syresatt, kall maskinperfusion
2021-01-28 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
XVIVO offentliggör bokslutskommuniké 2020
2021-01-28 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
XVIVO presents Report on operations 2020
2021-01-08 16:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2021-01-08 16:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2021-11-30 08:00
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2021-11-30 08:00
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2021-10-28 21:58
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion has carried out a directed share issue of 746,269 shares at a subscription price of SEK 335 per share
2021-10-28 21:58
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion har genomfört en riktad nyemission av 746 269 aktier till en teckningskurs om 335 kronor per aktie
2021-10-28 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2021-10-28 17:31
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2021-10-28 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO has entered into an agreement to acquire the US organ recovery company Star Teams and finances the acquisition through a private placement of new shares
2021-10-28 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO har ingått avtal om att förvärva det amerikanska företaget för organhämtning, Star Teams, och finansierar förvärvet genom en nyemission av aktier
2021-10-21 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO offentliggör delårsrapport januari-september 2021
2021-10-21 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO presents interim report Januari-September 2021
2021-09-23 09:13
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Language correction: XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
2021-09-23 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO presenterar strategiska fokusområden för 2022-2026 på kapitalmarknadsdagen
2021-09-23 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
2021-07-13 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO offentliggör delårsrapport Januari-Juni 2021
2021-07-13 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
XVIVO presents interim report January-June 2021
2021-06-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2021-06-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2021-04-22 16:12
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2021-04-22 16:12
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
2021-04-21 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Interim report January-March 2021
Next